HF
NKTR icon

HRT Financial’s Nektar Therapeutics NKTR Stock Holding History

HRT Financial’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-70,667
Closed -$5.17M – 4981
2026
Q1 		$5.08M Sell
70,667
-102,776
-59% -$5.85M 0.01% 986
2025
Q4 		$7.33M Buy
173,443
+160,285
+1,218% +$8.97M 0.02% 583
2025
Q3 		$748K Buy
+13,158
New +$436K ﹤0.01% 1672
2025
Q2 		– Sell
-4,545
Closed -$46K – 3254
2025
Q1 		$46K Buy
+4,545
New +$59.4K ﹤0.01% 2247
2024
Q1 		– Sell
-4,700
Closed -$39K – 2827
2023
Q4 		$39K Buy
4,700
+2,422
+106% +$18.3K ﹤0.01% 1979
2023
Q3 		$20K Sell
2,278
-13,339
-85% -$128K ﹤0.01% 2074
2023
Q2 		$134K Sell
15,617
-9,657
-38% -$103K ﹤0.01% 1931
2023
Q1 		$266K Sell
25,274
-2,756
-10% -$83.4K ﹤0.01% 1785
2022
Q4 		$950K Buy
28,030
+12,510
+81% +$605K 0.01% 1006
2022
Q3 		$744K Buy
15,520
+7,956
+105% +$473K 0.01% 1124
2022
Q2 		$431K Sell
7,564
-15,097
-67% -$953K ﹤0.01% 1775
2022
Q1 		$1.83M Buy
+22,661
New +$3.35M 0.01% 677
2021
Q4 		– Sell
-2,098
Closed -$565K – 3774
2021
Q3 		$565K Buy
2,098
+52
+3% +$12.5K ﹤0.01% 1867
2021
Q2 		$526K Buy
2,046
+463
+29% +$128K ﹤0.01% 1718
2021
Q1 		$474K Buy
+1,583
New +$493K ﹤0.01% 1839
2020
Q4 		– Sell
-1,095
Closed -$272K – 2254
2020
Q3 		$272K Sell
1,095
-90
-8% -$28.3K 0.01% 1205
2020
Q2 		$411K Buy
+1,185
New +$370K 0.01% 860
2020
Q1 		– Sell
-760
Closed -$246K – 1165
2019
Q4 		$246K Sell
760
-182
-19% -$52.8K 0.01% 846
2019
Q3 		$257K Buy
+942
New +$345K 0.01% 1018
2018
Q3 		– Sell
-575
Closed -$421K – 467
2018
Q2 		$421K Buy
+575
New +$663K 0.15% 125

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's NKTR Position: Q2 2026 in Review

HRT Financial sold out of Nektar Therapeutics (NKTR) in Q2 2026, closing a stake of 70,667 shares — an estimated $5.17M sold.

HRT Financial first reported a position in NKTR in Q2 2018 and held it in 20 quarters. The position peaked at $7.33M in Q4 2025. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • HRT Financial reported no remaining Nektar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 70,667 Nektar Therapeutics shares in Q2 2026, an estimated $5.17M.
  • HRT Financial first reported a position in Nektar Therapeutics in Q2 2018 and held it in 20 quarters.
  • HRT Financial's Nektar Therapeutics position peaked at $7.33M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.